FEB 06, 2020 6:22 AM PST

Potential Cure for Coronavirus Found in Thailand

WRITTEN BY: Annie Lennon

Doctors in Thailand have successfully treated people affected by the coronavirus via a new drug cocktail made out of antiviral, flu and HIV medication. Although in early stages of understanding how effective the drug-trio is in fending off the virus, their findings may offer hope for a potential cure.

Having administered the treatment in Rajavithi Hospital in Bangkok, doctors have said that the new approach has significantly improved the condition of several patients in their care. In particular, the doctors highlighted the case of one 70-year-old woman from Wuhan, the epicentre of the virus, who had tested positive for the virus for ten days prior receiving the treatment. 

Dr Kriangska Atipornwanich, a lung specialist at Rajavithi Hospital said, “This is not the cure, but the patient’s condition has vastly improved. From testing positive for 10 days under our care, after applying this combination of medicine the test result became negative within 48 hours...The outlook is good but we still have to do more study to determine that this can be a standard treatment.”

The usage of these drugs to treat the virus leverages previous research conducted on treating MERS and SARS. Dr Margot Savoy, chair of family and community medicine at the Lewis Katz School of Medicine at Temple University said, “Because this novel coronavirus is in the same family as the recent new infections MERS and SARS, scientists can use the work they have been doing for those infections to apply to the 2019 coronavirus.”

Although some news organizations are reporting that the death rate from coronavirus is higher than the recovery rate, many health officials say that these statements are misleading. This comes as complete recovery from respiratory issues can take weeks, if not months, and that most viruses don’t have a cure. 

Thus, although doctors and researchers alike are scrambling to find solutions to the disease, as no current cure exists, with the trajectory of the disease still unknown, so far, the majority of care provided for the illness is more supportive in nature. This means that rather than treating the virus itself, it manages symptoms- including fevers, cough, vomiting and fatigue until the body is able to handle the virus on its own accord. 

 

Sources: Reuters, Interesting Engineering and Healthline 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
OCT 10, 2020
Drug Discovery & Development
Fishnet of Nanoparticles Traps Drug Molecules
OCT 10, 2020
Fishnet of Nanoparticles Traps Drug Molecules
‘Fishnet’ Nanoparticles Traps Drug Molecules A team at Northwestern University have casted a net of nanopart ...
OCT 13, 2020
Drug Discovery & Development
Uses of Tandem Mass Spectrometry (TMS)
OCT 13, 2020
Uses of Tandem Mass Spectrometry (TMS)
What is tandem mass spectrometry? A powerful analytical tool that is capable of characterizing complex mixtures in drug ...
NOV 08, 2020
Cell & Molecular Biology
Mouth Spray for Epidermolysis Bullosa in Development
NOV 08, 2020
Mouth Spray for Epidermolysis Bullosa in Development
Epidermolysis Bullosa (EB) is a rare genetic disorder that makes the skin incredibly fragile; it forms blisters and can ...
NOV 18, 2020
Cancer
Could Targeting the Proteasome be Effective Against Cancer?
NOV 18, 2020
Could Targeting the Proteasome be Effective Against Cancer?
One of the trickiest things about anti-cancer drug design is targeting. Today, most drugs on the market target critical ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
Loading Comments...